FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a pharmaceutical composition based on siponimod, which can be administered parenterally. In particular, the invention relates to a solution for parenteral administration containing siponimod in the form of an acid addition product with fumaric acid, which is a co-crystal; and a method of obtaining the said solution.
EFFECT: obtaining a composition for parenteral administration containing siponimod.
16 cl, 4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEUROACTIVE STEROID SOLUTIONS AND METHODS FOR ADMINISTRATION | 2016 |
|
RU2803464C2 |
| COMPOSITIONS WHICH CONTAIN EPOTHILONE, AND METHOD OF THEIR OBTAINING | 2005 |
|
RU2416407C2 |
| INJECTABLE COMPOSITIONS BASED ON URSODEOXYCHOLIC ACID | 2020 |
|
RU2805311C1 |
| S1P MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN | 2015 |
|
RU2715734C2 |
| IDENTIFICATION OF PATIENTS' REACTION TO ADMINISTRATION OF S1P RECEPTOR MODULATOR | 2013 |
|
RU2785736C2 |
| AQUEOUS PHARMACEUTICAL COMPOSITIONS BASED ON 1,2-DIHYDROPYRIDINE COMPOUNDS | 2019 |
|
RU2824582C2 |
| PHARMACEUTICAL FORM OF GEMCITABINE OF LARGE VOLUME FOR INFUSION AND KIT CONTAINING FORMULATIONS | 2013 |
|
RU2621144C2 |
| OCULAR COMPOSITIONS FOR DRUG-DELIVERY TO POSTERIOR SEGMENT OF THE EYE | 2014 |
|
RU2665953C2 |
| OPHTHALMIC FORMULATIONS FOR DRUG DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE | 2014 |
|
RU2768489C2 |
| ALKYLATED CYCLODEXTRIN COMPOSITIONS AND PROCESSES FOR PREPARING AND USING THE SAME RELATED APPLICATIONS | 2013 |
|
RU2615385C2 |
